Mid-Day Market Update: Crude Oil Falls Over 1%; Helbiz Shares Spike Higher

Midway through trading Friday, the Dow traded down 0.51% to 34,572.50 while the NASDAQ fell 0.78% to 15,062.99. The S&P also fell, dropping 0.72% to 4,441.64.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 41,788,110 cases with around 670,020 deaths. India confirmed a total of at least 33,381,720 cases and 444,240 deaths, while Brazil reported over 21,069,010 COVID-19 cases with 589,240 deaths. In total, there were at least 227,118,470 cases of COVID-19 worldwide with more than 4,671,540 deaths, according to data compiled by Johns Hopkins University.


Leading and Lagging Sectors


Consumer discretionary shares gained 0.1% on Friday. Meanwhile, top gainers in the sector included 1847 Goedeker Inc. GOED, up 6% and Lucid Group, Inc. LCID up 10%.


In trading on Friday, materials shares tumbled 2%.


Top Headline

The University of Michigan's consumer sentiment index rose to 71 in September from a decade-low reading of 70.3 in August. However, analysts were expecting a reading of 72.

 

Equities Trading UP


Helbiz, Inc. HLBZ shares shot up 96% to $17.60 after the company announced its media unit has entered into an agreement with FOX Networks to broadcast the Italian Serie B championship across the USA and the Caribbean.


Shares of Corvus Pharmaceuticals, Inc. CRVS got a boost, shooting 83% to $4.1446.


Innate Pharma S.A. IPHA shares were also up, gaining 46% to $8.39 as its partner AstraZeneca Plc AZN presented results from the COAST Phase 2 trial during the European Society for Medical Oncology (ESMO21) Congress 2021. SVB Leerink maintained Innate Pharma with an Outperform and raised the price target from $7 to $9.

Check out these big movers of the day


Equities Trading DOWN

Protagonist Therapeutics, Inc. PTGX shares tumbled 61% to $17.80 after the company reported the FDA placed a clinical hold on rusfertide development program.

Shares of TCR2 Therapeutics Inc. TCRR were down 32% to $10.65 after the company announced interim results from an ongoing Phase 1/2 trial of gavo-cel for the treatment of refractory mesothelin-expressing solid tumors.

IronNet Cybersecurity, Inc. IRNT was down, falling 20% to $33.18. IronNet shares climbed over 28% on Thursday amid increased retail investor interest in the stock on social media.


Commodities


In commodity news, oil traded down 1.3% to $71.65, while gold traded down 0.3% to $1,751.00.


Silver traded down 1.7% Friday to $22.415 while copper fell 0.5% to $4.2605.


Euro zone

European shares were mostly lower today. The eurozone’s STOXX 600 fell 0.45%, the Spanish Ibex Index rose 0.94% and the German DAX 30 dropped 0.81%. Meanwhile, the London’s FTSE 100 fell 0.49%, French CAC 40 slipped 0.32% and Italy’s FTSE MIB fell 0.49%.

The Eurozone annual inflation rate was confirmed at 3.0% for August, while construction output increased 3.3% year-over-year in July. The Eurozone current account surplus increased to EUR 30.2 billion in July from EUR 26.1 billion in the year-ago period. Retail sales volumes in the UK fell 0.9% in August.


Economics

The University of Michigan's consumer sentiment index rose to 71 in September from a decade-low reading of 70.3 in August. However, analysts were expecting a reading of 72.


The Baker Hughes North American rig count report for the latest week will be released at 1:00 p.m. ET.

Check out the full economic calendar here

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsPenny StocksEurozoneCommoditiesSmall CapGlobalIntraday UpdateMarketsMid-Day Market Update
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!